Arkolith/Insider Trading/ALNA/Form 4

Brenner Louis MD

President and CEO, DirectorAllena Pharmaceuticals, Inc. (ALNA) · full profile →Form 4 · filed Nov 17, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$33K
Net Open-Market Flow
-$33K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2021Sell(S)40K$0.81$33K289K
Nov 15, 2021Option exercise(M)126K——329K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 15, 2021Option exercise(M)126K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-065147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML